Product
Acoramidis
1 clinical trial
2 indications
Indication
Amyloid CardiomyopathyIndication
Transthyretin-RelatedClinical trial
An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants With Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)Status: Active (not recruiting), Estimated PCD: 2028-04-15